Pharma-Bio Serv, Inc. (PBSV)

Revenue by Segment

Financials in millions USD. Fiscal year is November - October.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Oct 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020	Oct 31, 2019	Oct 31, 2018	Oct 31, 2017	Oct 31, 2016
Puerto Rico Consulting	4.64M	5.69M	8.04M	12.14M	14.68M
Puerto Rico Consulting Growth	-18.51%	-29.21%	-33.80%	-17.29%	-19.40%
United States Consulting	2.62M	3.16M	4.67M	4.56M	2.72M
United States Consulting Growth	-17.13%	-32.32%	2.51%	67.53%	19.15%
Europe Consulting	1.73M	571.18K	4.26M	2.65M	2.33M
Europe Consulting Growth	202.38%	-86.59%	60.72%	13.80%	180.93%
Other	16.67K	85.78K	6.23K	47.65K	384.49K
Other Growth	-80.57%	1275.99%	-86.92%	-87.61%	62.12%
Total	9.00M	9.51M	16.98M	19.40M	20.12M
Total Growth	-5.34%	-43.99%	-12.48%	-3.56%	-6.72%

Revenue by Geography

Financials in millions USD. Fiscal year is November - October.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Oct 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020	Oct 31, 2019	Oct 31, 2018	Oct 31, 2017	Oct 31, 2016
Puerto Rico	4.64M	5.69M	8.04M	12.14M	14.68M
Puerto Rico Growth	-18.51%	-29.21%	-33.80%	-17.29%	-19.40%
United States	2.62M	3.16M	4.67M	4.56M	2.72M
United States Growth	-17.14%	-32.32%	2.50%	67.51%	19.19%
Europe	1.73M	571.00K	4.26M	2.65M	2.33M
Europe Growth	202.45%	-86.60%	60.69%	13.83%	180.94%
Other	17.00K	86.00K	6.00K	48.00K	384.00K
Other Growth	-80.23%	1333.33%	-87.50%	-87.50%	62.03%
Total	9.00M	9.51M	16.98M	19.40M	20.12M
Total Growth	-5.34%	-43.99%	-12.49%	-3.56%	-6.72%

Source: S&P Global Market Intelligence.